The Turkish Society of Nephrology 2020 Registry: COVID-19 Report

Objective: The Turkish Society of Nephrology Registry collects data on hemodialysis, peritoneal dialysis, and transplantation annually. Registry reports are printed every year as a booklet, and this is the 30th year of registry reports. Unlike previous years, registry reports include an additional chapter this year due to the coronavirus disease 2019 pandemic. The effect and results of the coronavirus disease-2019 pandemic on kidney replacement therapies are presented in the 2020 reports.

Methods: We obtained data from the Turkish Society of Nephrology 2020 registry report and summarized the coronavirus disea se-19 -asso ciate d data and statistics for kidney replacement therapy patients.

Results: The number of patients on kidney replacement therapy was 83 350 individuals at the end of 2020. A total of 1610 kidney replacement therapy patients were infected with SARS-CoV-2. Hemodialysis had the highest frequency of coronavirus disease 2019 (19.5%), followed by transplantation (12.2%) and peritoneal dialysis (8.6%). The mortality rate was highest in peritoneal dialysis patients with 29.6%, 24.4% in HD, and 11.2 % in kidney transplant recipients.

Conclusion: Coronavirus disease 2019 has significant effects on the survey of patients undergoing kidney replacement therapy through severe complications.

Cite this article as: Kocyigit I, Seyahi N, Ates K, Suleymanlar G. The Turkish Society of Nephrology 2020 registry: COVID-19 report. Turk J Nephrol. 2022;31(4):279-283.